Table 5.

Net benefit of immediate transplant during a pandemic compared to deferred transplant outside of a pandemic: relatively higher infection rates and case fatality rates (CFR)

Age (yr)	Baseline [95% CI]	1.5-fold higher CFR in transplant recipients relative to dialysis/wait list	1.5 Higher infection rate in transplant relative to dialysis/wait list	1.5 Higher infection rate in wait list; 1.5-fold higher CFR in transplant	1.5 Higher infection rate in wait list; CFR 2-fold higher in transplant than wait list
25
LYs	0.48 [0.12–0.84]	0.26 [–0.13 to 0.60]	0.21 [–0.13 to 0.55]	0.42 [0.08–0.76]	0.20 [–0.13 to 053]
QALYs	0.63 [0.23–1.03]	0.42 [0.06–0.78]	0.35 [–0.03 to 0.73]	0.57 [0.17–0.97]	0.36 [–0.04 to 0.76]
40
LYs	1.32 [1.06–1.58]	1.10 [0.85–1.35]	1.04 [0.79–1.29]	1.25 [0.99–1.51]	1.03 [0.76–1.20]
QALYs	1.63 [1.35–1.91]	1.42 [1.12–1.72]	1.35 [1.05–1.65]	1.56 [1.27–1.85]	1.35 [1.06–1.64]
50
LYs	1.32 [1.17–1.47]	0.81 [0.66–0.96]	0.83 [0.68–0.98]	1.15 [0.98–1.32]	0.66 [0.51–0.81]
QALYs	1.67 [1.50–1.84]	1.18 [1.00–1.36]	1.18 [1.00–1.36]	1.50 [1.32–1.68]	1.02 [0.84–1.20]
60
LYs	0.90 [0.81–0.98]	0.15 [0.07–0.23]	0.23 [0.16–0.30]	0.65 [0.57–0.73]	–0.06 [–0.16 to 0.04]
QALYs	1.23 [1.13–1.33]	0.28 [0.18–0.38]	0.56 [0.46–0.66]	0.96 [0.86–1.06]	0.27 [0.16–0.38]
70
LYs	0.32 [0.26–0.38]	–0.33 [–0.39 to –0.27]	–0.25 [–0.29 to –0.21]	0.13 [0.08–0.18]	–0.47 [–0.53 to –0.41]
QALYs	0.62 [0.57–0.67]	–0.01 [–0.07 to 0.05]	0.06 [0.01–0.11]	0.41 [0.32–0.50]	–0.18 [–0.24 to –0.12]

Based on 12,000 cases per 100,000 patient years in general population; 24,000 cases per 100,000 (end-stage kidney disease) ESKD patient years; 1.5-fold higher in wait list patients is equal to 36,000 case per 100,000 per wait list patient years. LYs, life years; QALYs, quality adjusted life years.